MGRO

MustGrow Biologics Corp. (MGROF)

Market Closed
5 Dec, 20:00
OTCQB OTCQB
$
0. 42
+0.02
+4%
$
41.63M Market Cap
0 P/E Ratio
0% Div Yield
2,100 Volume
0 Eps
$ 0.4
Previous Close
Day Range
0.4 0.43
Year Range
0.37 1.25
Want to track MGROF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

MGROF closed Friday higher at $0.42, an increase of 4% from Thursday's close, completing a monthly decrease of -14.23% or $0.07. Over the past 12 months, MGROF stock lost -53.83%.
MGROF is not paying dividends to its shareholders.
The last earnings report, released on Nov 25, 2025, exceeded the consensus estimates by 0.01%. On average, the company has fell short of earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTCQB (USD).

MGROF Chart

Similar

Leatt Corporation
$ 9.97
+0.2%
Telescope Innovations Corp.
$ 0.28
+21.74%
Cell Source Inc.
$ 0.38
0%
Nascent Biotech Inc.
$ 0
0%
Inhibitor Therapeutics Inc.
$ 0.05
0%
MustGrow Biologics eyes strong finish to 2025 as it grows revenue, margins during Q3

MustGrow Biologics eyes strong finish to 2025 as it grows revenue, margins during Q3

MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF), a provider of regenerative agriculture solutions, reported record third quarter financial results as it expands its presence in Canadian and US markets. Revenue was $0.8 million for the quarter, compared with no revenue in the year-ago period.

Proactiveinvestors | 1 week ago
MustGrow Biologics reports record second quarter revenue

MustGrow Biologics reports record second quarter revenue

MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF), a provider of innovative regenerative agriculture solutions, has reported record revenue for the second quarter, with sales of $2.8 million for the three months ended June 30, 2025. This compares with no recorded revenue in the same quarter of 2024.

Proactiveinvestors | 3 months ago
MustGrow Biologics launches $3M private placement

MustGrow Biologics launches $3M private placement

MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) said on Wednesday it plans to raise up to C$3 million through a non-brokered private placement, as the agricultural biotech firm looks to ramp up production of its mustard-derived soil bioproducts. The financing will see the company issue up to 4.29 million units at C$0.70 each, with each unit comprising one common share and one five-year warrant exercisable at C$0.90.

Proactiveinvestors | 4 months ago

MustGrow Biologics Corp. (MGROF) FAQ

What is the stock price today?

The current price is $0.42.

On which exchange is it traded?

MustGrow Biologics Corp. is listed on OTCQB.

What is its stock symbol?

The ticker symbol is MGROF.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 41.63M.

Has MustGrow Biologics Corp. ever had a stock split?

No, there has never been a stock split.

MustGrow Biologics Corp. Profile

Biotechnology Industry
Healthcare Sector
Mr. Corey J. Giasson B.Sc., MBA CEO
OTCQB Exchange
CA62822A1030 ISIN
US Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

MustGrow Biologics Corp. is a pioneering agricultural biotech entity that zeroes in on the research, development, and commercial deployment of innovative, natural bio-based solutions targeted at pest and weed management. Originated as Duport Capital Ltd, it underwent a rebranding to its current name in March 2018 and was formally constituted in 2014. MustGrow is dedicated to offering eco-friendly, sustainable alternatives to traditional chemical pesticides and herbicides, leveraging the naturally potent properties of mustard seed. Situated in Saskatoon, Canada, the company is at the forefront of integrating agricultural practices with biotechnological innovations to address critical challenges in crop protection and soil health.

Products and Services

  • Preplant Soil Biofumigation
  • A groundbreaking technology focused on managing soil-borne diseases and pest infestations across a wide array of crops including fruits, vegetables, and more. This solution emphasizes environmental sustainability by using mustard seed derivatives to secure crops from underground threats, thereby enhancing yield and crop health.

  • TerraMG
  • TerraMG is a proprietary soil biopesticide technology derived from mustard seeds, designed for pre-plant soil treatment against diseases and pests. Its application spans across various crops such as fruits & vegetables, bananas, canola, and pulses, offering a natural, effective defense mechanism that bolsters plant vitality and resilience against soil-borne challenges.

  • Bioherbicide Development
  • MustGrow is actively engaged in formulating bioherbicides aimed at controlling unwanted plant growth. Tailored for both organic agriculture and the home & garden markets, as well as broader agricultural venues, these bioherbicides represent a significant leap toward sustainable farming by eliminating reliance on synthetic weed control methods.

  • Postharvest Food Preservation
  • Addressing the critical phase of postharvest, MustGrow has ventured into developing applications that counteract sprouting, diseases, and pathogens in stored foods and during food preservation. This innovation is key in extending shelf life, maintaining food quality, and reducing waste, thereby supporting global food security initiatives.

Contact Information

Address: 1005 ? 201 1st Avenue South, Saskatoon, SK, Canada, S7K 1J5
Phone: 306-668-2652